Representative Literature References

Click a row to open its literature reference.

Product

Separation Mode

Broad Sample Type

Specific Sample

Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Next View All

Year

Product

Sep. Mode

Broad Sample Category

Specific Sample

Title

2020	BioMix SEC-300	214300-7830	SEC	BsAbs	BsAbs	Characterization of Bispecific Antibody Production in Cell Cultures by Unique Mixed Mode Size Exclusion Chromatography Anal. Chem. 2020, 92, 13, 9312–9321
2020	Zenix-C SEC-300	233300-4630	SEC	Protein	Human interleukin 11α receptor	The structure of the extracellular domains of human interleukin 11α receptor reveals mechanisms of cytokine engagement Protein Structure and Folding Volume 295, Issue 24, p8285-8301, June 2020
2020	SRT-C SEC-300	235300-7830	SEC	Enzymes	Human diacylglycerol O-acyltransferase-1 (hDGAT1), from cell memebranes.	Structure and mechanism of human diacylglycerol O-acyltransferase 1 Nature volume 581, pages329–332 (2020)
2020	Proteomix SCX-NP5, PEEK	401NP5P-4625	IEX	Antibody	IgG2 isoforms	Optimizing TNFR2 antagonism for immunotherapy with tumor microenvironment specificity Journal of Leukocyte Biology Volume 107, Issue 6 June 2020 Pages 971-980
2020	SRT-10C SEC-100	239100-10030	SEC	Antibody	Synthetic nanobodies	Generation of synthetic nanobodies against delicate proteins Nature Protocols volume 15, pages1707–1741 (2020)
2020	SRT-10C SEC-300	239300-21230	SEC	BsMAb	Recombinant T cell receptors (TCR)/TCR fragments	Computational stabilization of T cell receptors allows pairing with antibodies to form bispecifics Nature Communications volume 11, Article number: 2330 (2020)
2020	SRT SEC-300	N/A	SEC	Protein	HEX Antibody carrier or HEX-antibody complexes	Characterization and Control of Dynamic Rearrangement in a Self-Assembled Antibo
2020	SRT-C SEC-500	235500-21230	SEC	Protein	Protein	A Global Screen for Assembly State Changes of the Mitotic Proteome by SEC-SWATH-MS Cell Systems Volume 10, Issue 2, 26 February 2020, Pages 133-155.e6
2019	Proteomix HIC Butyl-NP5	431NP5-4605	HIC	ADC	MMAE-trastuzumab ADC	Homogeneous antibody-drug conjugates: DAR 2 anti-HER2 obtained by conjugation on isolated light chain followed by mAb assembly
2019	Proteomix HIC Butyl-NP5	431NP5-4603	HIC	ADC	Site-specific ADC	Design and characterization of homogenous antibody-drug conjugates with a drug-to-antibody ratio of one prepared using an engin eered antibody and a dual-maleimide pyrrolobenzodiazepine dimer

Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Next View All

Products | Privacy Policy | Career | Contact Us

By Separation Mode	By Brand	By Sample Based Application
Size Exclusion Ion Exchange Hydrophobic Interaction Ion Exclusion Sub-2 UHPLC Purification Reversed Phase Mixed-mode Phase HILIC View All	SEC-MALS Unix / Unix-C Zenix / Zenix-C SRT / SRT-C SRT-10 / SRT-10C Proteomix HIC / IEX Antibodix Carbomix Proteomix RP View All	ADC Antibody Biosimilar Carbohydrate Cell Lysate DNA/RNA Fusion Protein Glycan Glycoprotein Heparin	Insulin Membrane Protein Organic Acid PEG/PEGylated Protein Peptide Polymer Protein Vaccine/VLP Others